Any feedback?
Literature summary extracted from
- Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines unexpected therapeutic properties (2008), J. Inflamm., 5, 17.
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.1.1.4 | lysophosphatidylcholines | inhibitory plasma compounds, profile determination by mass spectroscopy, overview | Rattus norvegicus |  |
| 3.1.1.4 | additional information | no inhibition by decanoyl lysophosphatidylcholine in vitro | Rattus norvegicus | |
| 3.1.1.4 | palmitoyl lysophosphatidylcholines | competitive product inhibition | Rattus norvegicus | |
| 3.1.1.4 | stearoyl lysophosphatidylcholines | competitive product inhibition | Rattus norvegicus |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 3.1.1.4 | extracellular | the enzyme is secreted | Rattus norvegicus | - |
- |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.1.1.4 | Rattus norvegicus | - |
female Sprague Dawley rats | - |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 3.1.1.4 | blood plasma | - |
Rattus norvegicus | - |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.1.1.4 | PLA2 | - |
Rattus norvegicus |
pH Optimum
| EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|---|
| 3.1.1.4 | 7.4 | - |
assay at | Rattus norvegicus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
